Examples of 'liquid pharmaceutical formulation' in a sentence
Meaning of "liquid pharmaceutical formulation"
liquid pharmaceutical formulation: A medicinal product in liquid form that is specifically designed for administration as a pharmaceutical or therapeutic treatment. This phrase is commonly used in the pharmaceutical industry, healthcare sector, or scientific research related to drug development
How to use "liquid pharmaceutical formulation" in a sentence
Basic
Advanced
liquid pharmaceutical formulation
Other additives to the liquid pharmaceutical formulation.
A liquid pharmaceutical formulation comprising.
Amount of the nicotine in the liquid pharmaceutical formulation.
A liquid pharmaceutical formulation according to any preceding claim comprising a surfactant.
Examples on embodiments and manufacturing of the liquid pharmaceutical formulation.
Use of the liquid pharmaceutical formulation.
This invention also relates to use of said liquid pharmaceutical formulation.
Optionally the liquid pharmaceutical formulation contains a surfactant which is pharmaceutically acceptable.
Other additives may be added optionally to the liquid pharmaceutical formulation.
This invention relates to a liquid pharmaceutical formulation for delivering nicotine to a subject.
A nebulizer comprises a container having a reservoir which contains a liquid pharmaceutical formulation.
Optionally the liquid pharmaceutical formulation contains one or more flavouring agents.
One strategy may be to lower the frequency of administering the liquid pharmaceutical formulation.
The liquid pharmaceutical formulation product according to the invention may be used in therapy.
The invention provides a stable liquid pharmaceutical formulation as defined above.
See also
The liquid pharmaceutical formulation for use according to the invention is a buffered alkaline liquid formulation.
The liquid phase of the present liquid pharmaceutical formulation may comprise water.
A liquid pharmaceutical formulation according to claim 1 comprising a surfactant.
This invention relates to a liquid pharmaceutical formulation containing Zotepine.
A liquid pharmaceutical formulation according to claim 1, further comprising a preservative.
Technical Field This invention relates to a liquid pharmaceutical formulation for delivering nicotine to a subject.
A liquid pharmaceutical formulation according to any preceding claim comprising,.
The formulation of claim 1 which is a liquid pharmaceutical formulation.
A liquid pharmaceutical formulation according to claim 1, wherein the polyol is mannitol.
In some aspects, the pharmaceutical formulation is a liquid pharmaceutical formulation.
The liquid pharmaceutical formulation of claim 1, wherein the therapeutic protein is an antibody.
In a further particular embodiment of the invention, the liquid pharmaceutical formulation comprises polysorbate 80.
The stable liquid pharmaceutical formulation of claim 1, wherein the buffering agent is histidine.
The article of claim 27, wherein said stable liquid pharmaceutical formulation comprises 108 mg of antibody.
A liquid pharmaceutical formulation according to claim 1 wherein the antibody is a humanized or human antibody.
The anti-a4B7 antibody in the stable liquid pharmaceutical formulation of the invention can be vedolizumab.
A liquid pharmaceutical formulation comprising, micro-granules comprising an enterically coated proton pump inhibitor, and.
The use of claim 11 or 12 wherein said human IFN-Y is administered as a liquid pharmaceutical formulation.
As mentioned earlier, the solid or liquid pharmaceutical formulation according to the invention contains a disaccharide.
A liquid pharmaceutical formulation according to claim 7 wherein the antibody neutralizes CSF1R.
Thus, in a preferred embodiment, the liquid pharmaceutical formulation is preferably a pediatric and / or geriatric formulation.
A liquid pharmaceutical formulation according to claim 1 wherein the antibody specifically binds human CSF1R.
Further, the present liquid pharmaceutical formulation provides nicotine in a form being directly absorbable by a subject.
A liquid pharmaceutical formulation according to claim 1 comprising,.
Thus a controlled-release liquid pharmaceutical formulation which were easy to prepare would represent a significant advance.
Liquid pharmaceutical formulation for the prolonged release of active principle ( s ) ( AP ), wherein,.
The stable liquid pharmaceutical formulation of claim 1, wherein said surfactant is polysorbate 80.
A liquid pharmaceutical formulation according to claim 1 comprising at least 50 mg / ml antibody.
A liquid pharmaceutical formulation according to claim 9, wherein the pH of the formulation is from 6 to 7.
A liquid pharmaceutical formulation according to any of the claims 1 or 2, in which interferon-beta is recombinant.
The stable liquid pharmaceutical formulation of claim 12, wherein the antioxidant or chelator is citrate.
Preferably the liquid pharmaceutical formulation comprises a buffer with a pH between 3 and 4 ; more preferably, acetate buffer.
The liquid pharmaceutical formulation for use of claim 8, which is administered in a 30 minute IV infusion.
A liquid pharmaceutical formulation according to claim 1 comprising sucrose at a concentration of 20 mM to 200 mM.
A liquid pharmaceutical formulation according to claims 1 or 2 comprising sucrose at a concentration of 20 mM to 200 mM.
You'll also be interested in:
Examples of using Pharmaceutical
Show more
The pharmaceutical sector faces many problems
Thiomersal is used in some pharmaceutical manufacturing processes
A pharmaceutical rep left that here on tuesday
Examples of using Liquid
Show more
If liquid had been spilled into the product
Visual and electric liquid level monitoring
Liquid or sundries are forbidden to enter the charger
Examples of using Formulation
Show more
Reduction in budget formulation cycle time assessed
Formulation and communication of conditional interpretative declarations
Child rights policy formulation and coordination
